In these mice, neuroligin-3 (Nlgn3) is shed in the Nf1-mutant (Nf1+/neo) optic nerve in an activity-dependent manner, such that genetic or pharmacological blockade of Nlgn3 shedding inhibits glioma initiation and progression22. Here, NLGN3 is linked to central nervous system cancer.